At the IGTP TODAY

News

- Research

IGTP-led study identifies an epigenetic signature with prognostic value in metastatic thyroid cancer

Researchers from the Endocrine Tumours group, in collaboration with five university hospitals, have conducted the first comprehensive study of DNA methylation patterns in metastatic differentiated thyroid cancer (DTC). Published in the journal Thyroid, the study identifies an epigenetic signature comprising 156 CpG sites in primary tumours that could help stratify patients according to their risk of developing distant metastases.

- Research

A study led by the CIBEREHD group at Hospital Germans Trias demonstrates for the first time how to reduce the number of colonoscopies and improve the follow-up of patients with Crohn’s disease

Specialists from the Digestive System Department at the Hospital Germans Trias and the Inflammatory Bowel Disease Research Group (GReMII) at IGTP have led and published a unique study that represents an improvement in the monitoring and treatment of patients who have undergone surgery due to one of the main inflammatory bowel diseases: Crohn's disease.

- Campus Can Ruti, Research

Researchers use the Hallmarks of Cancer to get a new perspective on tumour growth

A team led by the Cancer Immunogenomics group at IJC, BSC and IGTP shows, for the first time, that within a tumour, the expression of the different hallmarks of cancer is not cell-specific, but rather position-specific. Under this new light, tumour architecture emerges as a valuable source of information to understand tumour dynamics and predict its sensitivity to anticancer drugs.